DAY 41
Health & Longevity: Sexual Health & Function
Hormones, Pelvic Floor, Vessels & Bonds
2026-06-27 · BigCat's Vitality Protocol
Evidence base: large cohorts + RCT/meta-analyses; hormone & pelvic-floor guidance drawn from the Endocrine Society, Cochrane, NAMS, and Attia/Haver protocols
SUB · Sex Hormones / Endocrine
Cohort + RCT
Sex Hormones & Aging: Slope vs Cliff
Gradual Decline in Men, a Cliff in Women
One-Sentence Takeaway
Male testosterone falls about 1% per year after 30 (a gentle slope); female estrogen drops off a cliff at the menopause transition. Hormone therapy treats people with symptoms + lab-confirmed deficiency — it is not a universal anti-aging switch.
Science + Mechanism
Sex hormones govern muscle, bone density, libido, mood, glucose/lipid metabolism, and vascular endothelium. Male testosterone declines slowly and most men stay in range; true hypogonadism requires two morning total-testosterone readings < 264 ng/dL (~9.2 nmol/L) plus symptoms. Women face years of wild estradiol swings around the final period, then a sharp drop, driving vasomotor symptoms, bone loss, and genitourinary atrophy. The TRAVERSE trial (2023, NEJM, n=5246) showed that in confirmed-hypogonadal men, properly dosed testosterone did not raise major cardiovascular events — settling a long-running safety debate.
Actionable Protocol
• Men — what to test: morning (8–10 am) total + free testosterone + SHBG + LH; recheck low values before acting.
• Women — what to test: perimenopause is diagnosed by symptoms + menstrual history; a single FSH value means little — don't decide off "a hormone test."
• Treatment threshold: TRT only for confirmed hypogonadism (low T + symptoms), monitoring hematocrit and PSA.
• Lifestyle first: sleep, fat loss, resistance training, and limiting alcohol can meaningfully raise endogenous testosterone — often without drugs.
For Women + Common Myths
Women's lens: menopausal hormone therapy (MHT) follows the "timing hypothesis" — started before 60 or within 10 years of menopause, benefits (hot-flash control, bone protection, relief of genitourinary symptoms) outweigh risks (NAMS 2022 position). The 2002 WHI scare came from a late-starting, average-age-63 cohort and has since been reinterpreted. Testosterone in women is used mainly for low libido (HSDD) — off-label but evidence-backed.
Myth 1: testosterone = universal anti-aging tonic → no benefit if T is normal, and it causes testicular atrophy, infertility, and erythrocytosis.
Myth 2: testosterone causes prostate cancer → large datasets find no causal link ("saturation model").
Myth 3: HRT is dangerous for everyone → that wrongly extrapolates late-starter findings to all.
This Week + Reflection
THIS WEEK
If you have persistent fatigue, falling libido, or strength loss, add "hormones" to your next check-up (men: a morning testosterone panel).
Reflect: before any drug, which three endogenous levers (sleep / body fat / training) can you optimize first?
SUB · Pelvic Floor / Rehab
RCT + Cochrane
Pelvic Floor: The Overlooked Core
A Muscle Group Both Sexes Have
One-Sentence Takeaway
The pelvic floor is a "hammock" supporting the bladder, uterus/prostate, and rectum — everyone has one. When too weak or too tight it causes leakage, prolapse, and reduced sexual function — and correct pelvic-floor training reverses it (Grade-A evidence).
Science + Mechanism
The floor is built mainly on the levator ani group, controlling continence, supporting pelvic organs, and contracting at orgasm. Pregnancy/delivery, age, obesity, chronic cough/constipation, and sustained intra-abdominal pressure weaken it; prolonged sitting and anxiety leave others with an over-tight (hypertonic) floor — which equally causes pain, urgency, and painful sex. A Cochrane review (Dumoulin 2018) found pelvic-floor muscle training (PFMT) makes women several-fold more likely to be "cured or improved" of stress incontinence — a first-line therapy. Post-prostatectomy PFMT likewise speeds continence recovery in men.
Actionable Protocol
• Find the right muscle first: imagine lifting/holding back urine or gas — without squeezing glutes, abs, thighs, or holding your breath.
• Dose: 3 sets/day, 8–12 contractions each; slow lift held 6–8 s + equal relaxation, plus a few quick contractions.
• Persist: allow 12 weeks for results, then maintain.
• Escalate: if leakage/prolapse/painful sex is stubborn, see a pelvic-floor physiotherapist (including assessing whether it's hypertonic and needs release, not strengthening).
For Women + Common Myths
Women's lens: about 1 in 3 women experience stress incontinence, peaking postpartum and in perimenopause; falling estrogen thins urethral/vaginal tissue, so local vaginal estrogen can be added. Not every problem is "too weak" — postpartum or chronic pelvic pain is often hypertonic, and blindly hammering Kegels makes it worse.
Myth 1: leakage is an inevitable part of aging → it's treatable, don't quietly rely on pads.
Myth 2: more Kegels is always better → a hypertonic floor needs relaxation and breathing, not more squeezing.
Myth 3: the pelvic floor is a women's issue → male continence and erectile rigidity depend on it too.
This Week + Reflection
THIS WEEK
Use cues ("at a red light / while brushing teeth") to do 3 proper pelvic-floor sets daily,
confirming no breath-holding or glute/thigh substitution.
Reflect: can you tell whether yours is "too weak" or "too tight"? If training doesn't help, should you switch direction?
SUB · Sexual Function / Cardiovascular
Prospective cohort + meta
Sexual Function: The Cardiovascular Canary
When ED Is an Early Warning, Not a Bedroom Issue
One-Sentence Takeaway
Erectile dysfunction (ED) is often an early alarm for coronary disease: penile arteries are narrower, so endothelial dysfunction shows up there first — on average 3–5 years before a cardiac event. ED is a whole-body signal to check your vessels, not just a bedroom problem.
Science + Mechanism
Erection depends on endothelial release of nitric oxide (NO), dilating the cavernosal arteries to engorge. Penile arteries are only 1–2 mm wide versus 3–4 mm for coronaries — so with the same endothelial disease and atherosclerosis, the smaller pipes clog first, and ED precedes angina (the "artery-size hypothesis"). Meta-analyses (e.g. Vlachopoulos) show ED significantly predicts future cardiovascular events and all-cause mortality. Female arousal is likewise a vasocongestive process, and female sexual dysfunction also tracks cardiovascular risk — just less studied.
Actionable Protocol
• Treat ED as a red flag: new, persistent ED → check blood pressure, lipids, fasting glucose/HbA1c, waist; estimate 10-year cardiovascular risk.
• Treat the root: quit smoking, lose fat, do regular aerobic + resistance training, control glucose and pressure — the same vessel-protecting plan improves erections.
• Medication: PDE5 inhibitors (e.g. sildenafil) are effective first-line; they are contraindicated with nitrates (severe hypotension).
• Women: for perimenopausal pain/dryness, local vaginal estrogen or lubricants are first-line, safe, and effective.
For Women + Common Myths
Women's lens: the genitourinary syndrome of menopause (GSM) — vaginal dryness, burning, recurrent UTIs — is common yet long unspoken. Low-dose local vaginal estrogen has minimal systemic absorption and can be used even by most women with a breast-cancer history under clinician guidance (NAMS position). Libido is a multifactorial product of hormones, vessels, psychology, and relationship — don't blame "hormones" alone.
Myth 1: ED is purely psychological → after 40, most cases have a vascular/metabolic component and warrant a check-up.
Myth 2: PDE5 drugs harm the heart → they're safe for most stable cardiovascular patients and reflect vascular benefit; the key is never combining with nitrates.
Myth 3: sexual problems are aging to accept → most are treatable and double as a health clue.
This Week + Reflection
THIS WEEK
Add "changes in sexual function" to your cardiovascular self-check — and if something is new and persistent, book a metabolic + vascular evaluation rather than quietly self-medicating.
Reflect: do you treat sexual function as an objective health gauge, or as something too private to mention?
SUB · Intimacy / Social Connection
Prospective cohort + meta
Intimacy & Bonds: A Hard Longevity Metric
Connection as Quantifiable as Lipids
One-Sentence Takeaway
Social connection and intimacy are quantifiable longevity factors: loneliness carries a mortality risk comparable to smoking 15 cigarettes a day. Sexual activity correlates with better mood, cardiovascular, and immune markers — but be honest that correlation ≠ causation.
Science + Mechanism
A Holt-Lunstad meta-analysis (2010, ~300,000 people) found strong social ties raise survival odds by about 50% — an effect size on par with quitting smoking and larger than exercise or obesity. Mechanisms: intimate contact and orgasm release oxytocin and endorphins, lowering cortisol, blood pressure, and inflammatory markers; stable relationships also impose healthy behavioral constraints (better sleep, diet, care-seeking). Sexual frequency correlates with fewer cardiovascular events (e.g. Hall 2010, MMAS cohort), but active people tend to be healthier to begin with — so treat the causal direction with caution.
Actionable Protocol
• Treat relationships as a health investment: schedule fixed, high-quality connection time (partner, friends, family) the way you schedule exercise.
• Physical touch: a few minutes of daily hugging/intimate contact triggers the oxytocin pathway.
• Fight loneliness actively: recognize its signals and meet face-to-face regularly (online doesn't substitute).
• Communication over technique: sexual satisfaction depends more on relationship quality and open communication than on frequency metrics.
For Women + Common Myths
Women's lens: perimenopausal libido change is multifactorial — hormones are only one input; poor sleep, mood, relationship satisfaction, a partner's health, and body image often weigh more. Blaming it all on "low estrogen" misses the more changeable levers. Female sexual response is more context- and emotion-driven, so communication itself is an effective "intervention."
Myth 1: sex and intimacy are for the young → the need for connection and activity spans the whole lifespan.
Myth 2: frequency = satisfaction → quality, safety, and communication are the key variables.
Myth 3: sexual activity directly "extends life" → mostly correlation, driven by the shared cause of health and relationship quality.
This Week + Reflection
THIS WEEK
Schedule one
phone-free, unhurried high-quality connection (a deep talk, a shared walk, or just holding each other) and treat it as a health habit equal to exercise.
Reflect: on your longevity checklist, which gets taken less seriously — "relationships" or "cholesterol"?
Going Deeper
Treating testosterone/estrogen as an "anti-aging switch" — where's the boundary?
Hormone therapy is replacement for confirmed deficiency; restoring levels to normal range recovers the corresponding functions. But in people who are already normal, exogenous hormones don't "extend life" and instead suppress the endogenous axis, risking erythrocytosis and clots. The key distinction is "correcting a deficiency" versus "supra-physiologic enhancement." For women, MHT's benefit–risk depends heavily on timing and personal history and should be individualized, not one-size-fits-all.
ED as a cardiovascular warning — how to weigh false positives and anxiety?
Treating ED as a signal genuinely catches metabolic/vascular disease early — a low-cost, high-value screening trigger. But not all ED is vascular (drugs, psychology, sleep, relationship can all cause it), and over-medicalizing breeds anxiety. The sensible rule: new, persistent, age-incongruent ED triggers a systematic evaluation — not panic every time.
Why is "more pelvic-floor work is always better" a dangerous intuition?
A muscle's job is to contract and release at will, not stay permanently clenched. A hypertonic floor (common in chronic pelvic pain, postpartum, chronic tension) fails to relax, and piling on Kegels worsens pain, urgency, and painful sex. First distinguish "weak" from "tight," and if needed use reverse training (relaxation, breathing, biofeedback). That's exactly why a professional assessment beats self-directed hammering.
How solid is the "social connection = longevity" causal chain?
The connection–mortality association is robust across many large cohorts, with a large effect size and plausible mechanisms (oxytocin/cortisol/behavioral constraint). But it's still observational: healthier people more easily sustain relationships (reverse causation), and socioeconomic status is a potential confounder. The conclusion is actionable (investing in relationships is nearly harmless and probably beneficial) — just don't treat it as causal proof of a single intervention. Shame and avoidance also let people accept treatable problems (leakage, ED, GSM, painful sex) as "fate"; de-stigmatizing and dashboarding sexual health is itself an underrated upgrade.